pulmonary surfactant发音

意思翻译

肺表面活性物质

相似词语短语

pulmonary───adj.肺的；有肺的；肺状的

pulmonary edema───[内科]肺水肿

pulmonary valve───[医]of pulmonary trunk肺动脉瓣：同valva trunci pulmonalis；[解剖]肺动脉瓣

detersive surfactant───去污表面活性剂

pulmonary circulation───[生理]肺循环；小循环

anionic surfactant───[助剂]阴离子型表面活性剂；阴离子型表面活化剂，阴离子型表面片性剂

foothill pulmonary───山麓肺

pulmonary tuberculosis───[内科]肺结核；n.肺结核

pulmonary hypertension───[生理]肺动脉高血压；肺动脉血压过高；[生理]肺动脉高压症

双语使用场景

Objective To study the efficacy of pulmonary surfactant in newborn infants with meconium aspiration syndrome.───目的探讨肺表面活性物质治疗新生儿胎粪吸入综合征的有效性及临床价值。

Objective to evaluate the clinical effect of pulmonary surfactant Curosurf in preventing respiratory distress syndrome of prematures.───目的探讨肺泡表面活性物质制剂固尔苏预防早产儿呼吸窘迫综合征的临床疗效。

Objective to study the changes of pulmonary surfactant in patients with acute respiratory distress syndrome (ARDS).───目的研究患急性呼吸窘迫综合征(ARDS)时病人肺泡表面活性物质的变化。

Objective: To explore the clinical effects of pulmonary surfactant on the treatment of neonatal respiratory distress syndrome (NRDS).───目的：探讨肺表面活性物质对新生儿呼吸窘迫综合征（NRDS）的治疗效果。

Effect of four mechanical ventilation modes on pulmonary surfactant in early stage after severe smoke inhalation injury in dogs.───机械通气对严重烟雾吸入伤犬早期肺表面活性物质的影响。

Incidence of Complications of the Respiratory Distress Syndrome Following Pulmonary Surfactant Replacement Therapy in Neonates───新生儿呼吸窘迫综合征应用肺表面活性物质治疗后并发症的对照研究

Isolation and purification of pulmonary surfactant-associated protein A from human amniotic fluid and its bioactivity assessment───入羊水中肺表面活性物质相关蛋白A的提纯及生物活性分析

Experimental study of pulmonary surfactant administration to the rabbits'lung grafts───肺表面活性物质对兔供肺作用的实验研究

Study of the Critical Micelle Concentrations of Pulmonary Surfactant───肺表面活性物质临界胶团浓度的实验研究

英语使用场景

AIM To investigate the ruthenium red (RR) staining on the visualizing of ultrastructures of pulmonary surfactant (PS) in injured lungs caused by bleomycin (BLM).

AIM: To evaluate the therapeutic efficacy of intratracheal instillation of porcine pulmonary surfactant (PPS) in rats with lipopolysaccharides (LPS)-induced early-stage ALI in this study.

Objective: To discuss the clinical value of pulmonary surfactant (PS) in the replacement therapy for premature infants with hyaline membrane disease (HMD).

Conclusion Pulmonary surfactant therapy in hyaline membrane disease of newborns can quickly correct the abnormal blood gas, and hence is worthy of being recommended in clinical practice.

Recent studies suggest that GM-CSF correlate with alveolar macrophage function, lung host defense reaction and pulmonary surfactant homeostasis.

Objective To explore the effect of pulmonary surfactant (PS) combined with mechanical ventilation on pulmonary hyaline membrane disease of newborn (HMD) in newborn.